|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
208,280,000 |
Market
Cap: |
1.95(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$5.09 - $15.86 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Recursion Pharmaceuticals is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, in vivo validation capabilities and a cross-functional team to discover medicines. Co.'s potential medicines include: REC-994 for the treatment of cerebral cavernous malformation; REC-2282 for the treatment of neurofibromatosis type 2; REC-4881 for the treatment of familial adenomatous polyposis; REC-3599 for the treatment of GM2 gangliosidosis; REC-3964 for the treatment of C. difficile colitis; REC-64917 for neural or systemic inflammation; and multiple simultaneous programs in fibrosis developing with Bayer AG.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
1,693,990 |
Total Buy Value |
$0 |
$0 |
$0 |
$12,897,789 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
27 |
Total Shares Sold |
567,946 |
1,097,598 |
2,193,115 |
3,020,700 |
Total Sell Value |
$5,420,056 |
$10,572,222 |
$21,602,157 |
$28,825,014 |
Total People Sold |
4 |
7 |
8 |
8 |
Total Sell Transactions |
23 |
46 |
97 |
149 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Gibson Christopher |
Chief Executive Officer |
|
2023-03-09 |
4 |
AS |
$7.77 |
$116,621 |
D/D |
(15,000) |
938,787 |
|
111% |
|
Gibson Christopher |
Chief Executive Officer |
|
2023-03-08 |
4 |
AS |
$8.09 |
$202,348 |
I/I |
(25,000) |
0 |
|
68% |
|
Gibson Christopher |
Chief Executive Officer |
|
2023-03-08 |
4 |
A |
$0.00 |
$0 |
I/I |
25,000 |
1,000 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2023-03-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
953,787 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2023-03-08 |
4 |
AS |
$8.10 |
$573,925 |
D/D |
(70,890) |
963,787 |
|
68% |
|
Gibson Christopher |
Chief Executive Officer |
|
2023-03-08 |
4 |
OE |
$2.48 |
$232,500 |
D/D |
93,750 |
1,034,677 |
|
- |
|
Borgeson Blake |
Director |
|
2023-03-07 |
4 |
AS |
$8.33 |
$73,989 |
D/D |
(8,885) |
7,585,172 |
|
62% |
|
Gibson Christopher |
Chief Executive Officer |
|
2023-03-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
963,710 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
966,710 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2023-03-02 |
4 |
AS |
$7.90 |
$19,767 |
I/I |
(2,500) |
0 |
|
51% |
|
Gibson Christopher |
Chief Executive Officer |
|
2023-03-02 |
4 |
A |
$0.00 |
$0 |
I/I |
2,500 |
1,000 |
|
- |
|
Gibson Christopher |
Chief Executive Officer |
|
2023-03-02 |
4 |
AS |
$7.92 |
$146,502 |
D/D |
(18,500) |
940,927 |
|
51% |
|
Gibson Christopher |
Chief Executive Officer |
|
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
18,500 |
956,427 |
|
- |
|
Mubadala Development Co Pjsc |
10% Owner |
|
2023-03-02 |
4 |
B |
$7.82 |
$522,354 |
I/I |
66,822 |
12,985,927 |
1.5 |
51% |
|
Mubadala Development Co Pjsc |
10% Owner |
|
2023-03-01 |
4 |
B |
$7.94 |
$388,082 |
I/I |
48,867 |
12,919,105 |
1.5 |
-15% |
|
Mubadala Development Co Pjsc |
10% Owner |
|
2023-02-28 |
4 |
B |
$7.97 |
$6,496 |
I/I |
815 |
12,870,238 |
1.5 |
-12% |
|
Mubadala Development Co Pjsc |
10% Owner |
|
2023-02-27 |
4 |
B |
$7.69 |
$403,725 |
I/I |
52,500 |
12,869,423 |
1.5 |
-11% |
|
Mubadala Development Co Pjsc |
10% Owner |
|
2023-02-24 |
4 |
B |
$7.64 |
$833,552 |
I/I |
109,118 |
12,816,923 |
1.5 |
-13% |
|
Larson Tina Marriott |
President and COO |
|
2023-02-23 |
4 |
AS |
$7.82 |
$62,540 |
D/D |
(8,000) |
427,844 |
|
-7% |
|
Larson Tina Marriott |
President and COO |
|
2023-02-23 |
4 |
OE |
$1.06 |
$8,480 |
D/D |
8,000 |
435,844 |
|
- |
|
Mubadala Development Co Pjsc |
10% Owner |
|
2023-02-23 |
4 |
B |
$7.79 |
$403,792 |
I/I |
51,864 |
12,707,805 |
1.5 |
-7% |
|
Mubadala Development Co Pjsc |
10% Owner |
|
2023-02-22 |
4 |
B |
$7.83 |
$399,016 |
I/I |
50,941 |
12,655,941 |
1.5 |
-7% |
|
Borgeson Blake |
Director |
|
2023-02-21 |
4 |
AS |
$7.73 |
$68,708 |
D/D |
(8,885) |
7,594,057 |
|
-3% |
|
Mubadala Development Co Pjsc |
10% Owner |
|
2023-02-21 |
4 |
B |
$7.74 |
$731,126 |
I/I |
94,418 |
12,605,000 |
1.5 |
-3% |
|
Mubadala Development Co Pjsc |
10% Owner |
|
2023-02-17 |
4 |
B |
$7.71 |
$488,986 |
I/I |
63,382 |
12,510,582 |
1.5 |
-8% |
|
628 Records found
|
|
Page 11 of 26 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|